Cargando…
Hyperglycemia in Severe and Critical COVID-19 Patients: Risk Factors and Outcomes
Background: Hyperglycemia is commonly seen in critically ill patients. This disorder was also seen in coronavirus disease 2019 (COVID-19) patients and was associated with a worse prognosis. The current study determined the prevalence, risk factors, and prognostic implications of hyperglycemia in COV...
Autores principales: | Le, Viet Tran, Ha, Quoc Hung, Tran, Minh Triet, Le, Ngoc Trong, Le, Van Tuyen, Le, Minh Khoi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356651/ https://www.ncbi.nlm.nih.gov/pubmed/35949446 http://dx.doi.org/10.7759/cureus.27611 |
Ejemplares similares
-
A Review of the In Vitro Inhibition of α-Amylase and α-Glucosidase by Chalcone Derivatives
por: Tran, Thanh-Dao, et al.
Publicado: (2023) -
Pharmacological Activities and Safety of Ganoderma lucidum Spores: A Systematic Review
por: Thuy, Nguyen Huu Lac, et al.
Publicado: (2023) -
A Sweet Paradox: Severe Insulin Resistance and Hyperglycemia in Asymptomatic COVID-19 Infection
por: Ramchandani, Bhanvi P, et al.
Publicado: (2023) -
Hemichorea-Hemiballism as a Manifestation of Hyperglycemia
por: Maia, Maria, et al.
Publicado: (2021) -
Stress-Induced Hyperglycemia: Consequences and Management
por: Vedantam, Deepanjali, et al.
Publicado: (2022)